330440001: Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)

SNOMED CT Concept\Pharmaceutical / biologic product (product)\Medicinal product (product)\...

\Medicinal product categorized by disposition (product)\Product containing immunomodulator (product)\Product containing betamethasone (medicinal product)\Product containing betamethasone in ocular dose form (medicinal product form)\Betamethasone- and neomycin-containing product in ocular dose form\Product containing only betamethasone and neomycin in ocular dose form (medicinal product form)\Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)
\Medicinal product categorized by disposition (product)\Product containing immunomodulator (product)\Product containing betamethasone (medicinal product)\Product containing betamethasone and neomycin (medicinal product)\Betamethasone and neomycin only product\Product containing only betamethasone and neomycin in ocular dose form (medicinal product form)\Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)
\Medicinal product categorized by disposition (product)\Product containing immunomodulator (product)\Product containing betamethasone (medicinal product)\Product containing betamethasone and neomycin (medicinal product)\Betamethasone- and neomycin-containing product in ocular dose form\Product containing only betamethasone and neomycin in ocular dose form (medicinal product form)\Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)
\Medicinal product categorized by disposition (product)\Product containing neomycin (medicinal product)\Product containing neomycin in ocular dose form (medicinal product form)\Betamethasone- and neomycin-containing product in ocular dose form\Product containing only betamethasone and neomycin in ocular dose form (medicinal product form)\Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)
\Medicinal product categorized by disposition (product)\Product containing neomycin (medicinal product)\Product containing betamethasone and neomycin (medicinal product)\Betamethasone and neomycin only product\Product containing only betamethasone and neomycin in ocular dose form (medicinal product form)\Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)
\Medicinal product categorized by disposition (product)\Product containing neomycin (medicinal product)\Product containing betamethasone and neomycin (medicinal product)\Betamethasone- and neomycin-containing product in ocular dose form\Product containing only betamethasone and neomycin in ocular dose form (medicinal product form)\Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)
\Medicinal product categorized by disposition (product)\Product containing hormone (product)\Product containing fluorinated corticosteroid (product)\Product containing betamethasone (medicinal product)\Product containing betamethasone in ocular dose form (medicinal product form)\Betamethasone- and neomycin-containing product in ocular dose form\Product containing only betamethasone and neomycin in ocular dose form (medicinal product form)\Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)
\Medicinal product categorized by disposition (product)\Product containing hormone (product)\Product containing fluorinated corticosteroid (product)\Product containing betamethasone (medicinal product)\Product containing betamethasone and neomycin (medicinal product)\Betamethasone and neomycin only product\Product containing only betamethasone and neomycin in ocular dose form (medicinal product form)\Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)
\Medicinal product categorized by disposition (product)\Product containing hormone (product)\Product containing fluorinated corticosteroid (product)\Product containing betamethasone (medicinal product)\Product containing betamethasone and neomycin (medicinal product)\Betamethasone- and neomycin-containing product in ocular dose form\Product containing only betamethasone and neomycin in ocular dose form (medicinal product form)\Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)
\Medicinal product categorized by disposition (product)\Product containing hormone (product)\Product containing glucocorticoid (product)\Product containing betamethasone (medicinal product)\Product containing betamethasone in ocular dose form (medicinal product form)\Betamethasone- and neomycin-containing product in ocular dose form\Product containing only betamethasone and neomycin in ocular dose form (medicinal product form)\Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)
\Medicinal product categorized by disposition (product)\Product containing hormone (product)\Product containing glucocorticoid (product)\Product containing betamethasone (medicinal product)\Product containing betamethasone and neomycin (medicinal product)\Betamethasone and neomycin only product\Product containing only betamethasone and neomycin in ocular dose form (medicinal product form)\Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)
\Medicinal product categorized by disposition (product)\Product containing hormone (product)\Product containing glucocorticoid (product)\Product containing betamethasone (medicinal product)\Product containing betamethasone and neomycin (medicinal product)\Betamethasone- and neomycin-containing product in ocular dose form\Product containing only betamethasone and neomycin in ocular dose form (medicinal product form)\Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)

\Medicinal product categorized by structure\Product containing steroid (product)\Product containing pregnane (product)\Product containing betamethasone (medicinal product)\Product containing betamethasone in ocular dose form (medicinal product form)\Betamethasone- and neomycin-containing product in ocular dose form\Product containing only betamethasone and neomycin in ocular dose form (medicinal product form)\Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)
\Medicinal product categorized by structure\Product containing steroid (product)\Product containing pregnane (product)\Product containing betamethasone (medicinal product)\Product containing betamethasone and neomycin (medicinal product)\Betamethasone and neomycin only product\Product containing only betamethasone and neomycin in ocular dose form (medicinal product form)\Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)
\Medicinal product categorized by structure\Product containing steroid (product)\Product containing pregnane (product)\Product containing betamethasone (medicinal product)\Product containing betamethasone and neomycin (medicinal product)\Betamethasone- and neomycin-containing product in ocular dose form\Product containing only betamethasone and neomycin in ocular dose form (medicinal product form)\Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)
\Medicinal product categorized by structure\Product containing steroid (product)\Corticosteroid and/or corticosteroid derivative-containing product\Product containing fluorinated corticosteroid (product)\Product containing betamethasone (medicinal product)\Product containing betamethasone in ocular dose form (medicinal product form)\Betamethasone- and neomycin-containing product in ocular dose form\Product containing only betamethasone and neomycin in ocular dose form (medicinal product form)\Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)
\Medicinal product categorized by structure\Product containing steroid (product)\Corticosteroid and/or corticosteroid derivative-containing product\Product containing fluorinated corticosteroid (product)\Product containing betamethasone (medicinal product)\Product containing betamethasone and neomycin (medicinal product)\Betamethasone and neomycin only product\Product containing only betamethasone and neomycin in ocular dose form (medicinal product form)\Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)
\Medicinal product categorized by structure\Product containing steroid (product)\Corticosteroid and/or corticosteroid derivative-containing product\Product containing fluorinated corticosteroid (product)\Product containing betamethasone (medicinal product)\Product containing betamethasone and neomycin (medicinal product)\Betamethasone- and neomycin-containing product in ocular dose form\Product containing only betamethasone and neomycin in ocular dose form (medicinal product form)\Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)
\Medicinal product categorized by structure\Product containing steroid (product)\Corticosteroid and/or corticosteroid derivative-containing product\Product containing glucocorticoid (product)\Product containing betamethasone (medicinal product)\Product containing betamethasone in ocular dose form (medicinal product form)\Betamethasone- and neomycin-containing product in ocular dose form\Product containing only betamethasone and neomycin in ocular dose form (medicinal product form)\Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)
\Medicinal product categorized by structure\Product containing steroid (product)\Corticosteroid and/or corticosteroid derivative-containing product\Product containing glucocorticoid (product)\Product containing betamethasone (medicinal product)\Product containing betamethasone and neomycin (medicinal product)\Betamethasone and neomycin only product\Product containing only betamethasone and neomycin in ocular dose form (medicinal product form)\Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)
\Medicinal product categorized by structure\Product containing steroid (product)\Corticosteroid and/or corticosteroid derivative-containing product\Product containing glucocorticoid (product)\Product containing betamethasone (medicinal product)\Product containing betamethasone and neomycin (medicinal product)\Betamethasone- and neomycin-containing product in ocular dose form\Product containing only betamethasone and neomycin in ocular dose form (medicinal product form)\Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)
\Medicinal product categorized by structure\Product containing glycoside (product)\Product containing aminoglycoside (product)\Product containing neomycin (medicinal product)\Product containing neomycin in ocular dose form (medicinal product form)\Betamethasone- and neomycin-containing product in ocular dose form\Product containing only betamethasone and neomycin in ocular dose form (medicinal product form)\Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)
\Medicinal product categorized by structure\Product containing glycoside (product)\Product containing aminoglycoside (product)\Product containing neomycin (medicinal product)\Product containing betamethasone and neomycin (medicinal product)\Betamethasone and neomycin only product\Product containing only betamethasone and neomycin in ocular dose form (medicinal product form)\Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)
\Medicinal product categorized by structure\Product containing glycoside (product)\Product containing aminoglycoside (product)\Product containing neomycin (medicinal product)\Product containing betamethasone and neomycin (medicinal product)\Betamethasone- and neomycin-containing product in ocular dose form\Product containing only betamethasone and neomycin in ocular dose form (medicinal product form)\Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)

\Product manufactured as ocular dose form (product)\Product containing betamethasone in ocular dose form (medicinal product form)\Betamethasone- and neomycin-containing product in ocular dose form\Product containing only betamethasone and neomycin in ocular dose form (medicinal product form)\Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)
\Product manufactured as ocular dose form (product)\Product containing neomycin in ocular dose form (medicinal product form)\Betamethasone- and neomycin-containing product in ocular dose form\Product containing only betamethasone and neomycin in ocular dose form (medicinal product form)\Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

3692832010 Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

3692834011 Betamethasone sodium phosphate 1 mg/g and neomycin sulfate 5 mg/g eye ointment en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)	Is a	Betamethasone+neomycin sulfate	false	Inferred relationship	Some
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)	Is a	Miscellaneous eye preparations	false	Inferred relationship	Some
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)	Has active ingredient	Betamethasone	false	Inferred relationship	Some
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)	Has active ingredient	Adrenal hormone	false	Inferred relationship	Some
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)	Is a	Product containing neomycin in topical dosage form	false	Inferred relationship	Some
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)	Is a	Product containing betamethasone in topical dosage form	false	Inferred relationship	Some
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)	Has active ingredient	Betamethasone sodium phosphate	false	Inferred relationship	Some
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)	Has active ingredient	Corticosterone	false	Inferred relationship	Some
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)	Has active ingredient	Neomycin sulfate	false	Inferred relationship	Some
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)	Has active ingredient	Skin anti-infective	false	Inferred relationship	Some
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)	Has active ingredient	Adrenal hormone agent	false	Inferred relationship	Some
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)	Has active ingredient	Glucocorticoid hormone	false	Inferred relationship	Some
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)	Has active ingredient	Bactericide	false	Inferred relationship	Some
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)	Has active ingredient	Local anti-infective	false	Inferred relationship	Some
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)	Is a	Product containing betamethasone in ophthalmic dosage form	false	Inferred relationship	Some
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)	Is a	Product containing neomycin in ophthalmic dosage form	false	Inferred relationship	Some
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)	Has manufactured dose form	Ocular dose form (dose form)	false	Inferred relationship	Some
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)	Has manufactured dose form	Eye ointment	true	Inferred relationship	Some
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)	Is a	Product containing betamethasone and neomycin (medicinal product)	false	Inferred relationship	Some
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)	Count of base of active ingredient	2	false	Inferred relationship	Some
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)	Has concentration strength numerator value	5	false	Inferred relationship	Some	2
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)	Has concentration strength numerator value	1	false	Inferred relationship	Some	1
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)	Has precise active ingredient	Betamethasone sodium phosphate	true	Inferred relationship	Some	1
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)	Has precise active ingredient	Neomycin sulfate	true	Inferred relationship	Some	2
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)	Has concentration strength denominator unit	g	true	Inferred relationship	Some	2
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)	Has basis of strength substance (attribute)	Betamethasone sodium phosphate	true	Inferred relationship	Some	1
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)	Has concentration strength numerator unit	mg	true	Inferred relationship	Some	2
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)	Has concentration strength denominator value	1	false	Inferred relationship	Some	2
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)	Has basis of strength substance (attribute)	Neomycin sulfate	true	Inferred relationship	Some	2
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)	Has concentration strength numerator unit	mg	true	Inferred relationship	Some	1
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)	Has concentration strength denominator value	1	false	Inferred relationship	Some	1
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)	Has concentration strength denominator unit	g	true	Inferred relationship	Some	1
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)	Is a	Product containing only betamethasone and neomycin in ocular dose form (medicinal product form)	true	Inferred relationship	Some
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)	Plays role	Antibacterial therapeutic role (role)	false	Inferred relationship	Some

Inbound Relationships

Type

Active

Source

Characteristic

Refinability

Group

Reference Sets

GB English

US English

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
3692832010	Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3692834011	Betamethasone sodium phosphate 1 mg/g and neomycin sulfate 5 mg/g eye ointment	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core